Back to Search Start Over

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway.

Authors :
Han, Jibo
Shi, Xiaowen
Zheng, Zhanxiong
Zhang, Bin
Shi, Fengjie
Jiang, Liqin
Xu, Jianjiang
Source :
Drug Design, Development & Therapy; 2018, Vol. 12, p3985-3997, 13p
Publication Year :
2018

Details

Language :
English
ISSN :
11778881
Volume :
12
Database :
Complementary Index
Journal :
Drug Design, Development & Therapy
Publication Type :
Academic Journal
Accession number :
133503147
Full Text :
https://doi.org/10.2147/DDDT.S184245